Related references
Note: Only part of the references are listed.Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
Bruno Nervi et al.
BLOOD (2009)
AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance
Kumudha Balakrishnan et al.
BLOOD (2009)
Isoform-selective phosphoinositide 3′-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach
Matthias Niedermeier et al.
BLOOD (2009)
B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406
Maite P. Quiroga et al.
BLOOD (2009)
The microenvironment in mature B-cell malignancies: a target for new treatment strategies
Jan A. Burger et al.
BLOOD (2009)
Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells
Asish K. Ghosh et al.
BLOOD (2009)
Mcl-1 Integrates the Opposing Actions of Signaling Pathways That Mediate Survival and Apoptosis
Caroline Morel et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Bone marrow microenvironment and the identification of new targets for myeloma therapy
K. Podar et al.
LEUKEMIA (2009)
Environment-mediated drug resistance: a major contributor to minimal residual disease
Mark B. Meads et al.
NATURE REVIEWS CANCER (2009)
Bcl-2-family proteins and hematologic malignancies: history and future prospects
John C. Reed
BLOOD (2008)
Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia
Constantine S. Tam et al.
BLOOD (2008)
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study
Michael J. Borowitz et al.
BLOOD (2008)
The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance
Mark B. Meads et al.
CLINICAL CANCER RESEARCH (2008)
Hedgehog-Induced Survival of B-Cell Chronic Lymphocytic Leukemia Cells in a Stromal Cell Microenvironment: A Potential New Therapeutic Target
Ganapati V. Hegde et al.
MOLECULAR CANCER RESEARCH (2008)
Bone marrow fibroblasts induce expression of PI3K/NF-κB pathway genes and a pro-angiogenic phenotype in CLL cells
J. Edelmann et al.
LEUKEMIA RESEARCH (2008)
mir-29 regulates Mcl-1 protein expression and apoptosis
J. L. Mott et al.
ONCOGENE (2007)
Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an angiogenic switch
Neil E. Kay et al.
LEUKEMIA RESEARCH (2007)
Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase
Shotaro Iwamoto et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Structural and functional basis of CXCL12 (strornal cell-derived factor-1α) binding to heparin
James W. Murphy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth:: role of stromal cells in follicular lymphoma pathogenesis
Patricia Ame-Thomas et al.
BLOOD (2007)
Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphomna
Jia Ruan et al.
CLINICAL CANCER RESEARCH (2006)
ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL)
SJ Richardson et al.
BLOOD (2006)
Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells
M Burger et al.
BLOOD (2005)
Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1α
M Nishio et al.
BLOOD (2005)
In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment
DA Sipkins et al.
NATURE (2005)
CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival
S Deaglio et al.
BLOOD (2005)
Enhancement of cell survival by stromal cell-derived factor-1/CXCL12 involves activation of CREB and induction of Mcl-1 and c-Fos in factor-dependent human cell line MO7e
EK Joo et al.
STEM CELLS AND DEVELOPMENT (2004)
VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia
YK Lee et al.
BLOOD (2004)
VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosis
S Le Gouill et al.
BLOOD (2004)
Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1
JT Opferman et al.
NATURE (2003)
DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells
A Cuconati et al.
GENES & DEVELOPMENT (2003)
Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia
T Matsunaga et al.
NATURE MEDICINE (2003)
B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules
NE Kay et al.
LEUKEMIA (2002)
Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cells
JA Burger et al.
LEUKEMIA & LYMPHOMA (2002)
Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy
AC Rawstron et al.
BLOOD (2001)
Share Paper
